3SBio, Inc. (TRSBF)
2.55
+0.03
(+1.19%)
USD |
OTCM |
May 19, 16:00
3SBio Market Cap : 6.377B for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 388.59M |
| CASI Pharmaceuticals, Inc. | 2.486M |
| Zai Lab Ltd. | 2.059B |
| Ascletis Pharma, Inc. | 1.762B |
| CanSino Biologics, Inc. | 961.00M |
Market Cap Related Metrics
| PE Ratio | 5.310 |
| PS Ratio | 2.538 |
| PEG Ratio | 0.012 |
| Price to Book Value | 42.43 |
| Price to Free Cash Flow | 4.828 |
| Price | 2.55 |
| Earnings Yield | 18.83% |
| PEGY Ratio | 0.012 |
| Operating PE Ratio | 4.245 |
| Normalized PE Ratio | 5.424 |